Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients—A Proof-of-Principle Trial

OBJECTIVES: Renal replacement therapy in coronavirus disease 2019 patients is complicated by increased activation of the coagulation system. This may worsen the quality of hemodialysis and contribute to a shortage of dialysis machines as well as plastic disposables during the pandemic. This study de...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Crit Care Explor
Главные авторы: Neumann-Haefelin, Elke, Widmeier, Eugen, Bansbach, Joachim, Kaufmann, Kai, Heinrich, Sebastian, Walz, Gerd, Bürkle, Hartmut, Kalbhenn, Johannes
Формат: Artigo
Язык:Inglês
Опубликовано: Wolters Kluwer Health 2020
Предметы:
Brief Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314355/
https://ncbi.nlm.nih.gov/pubmed/32696014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000155
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы